| 11 β-HSD1 | 11 –beta-hydroxysteroid dehydrogenase type 1 |
| 11 β-HSD2 | 11 –beta-hydroxysteroid dehydrogenase type 2 |
| ACE | angiotensin converting enzyme |
| ACEi | angiotensin-converting enzyme inhibitor |
| ADPKD | autosomal dominant polycystic kidney disease |
| AKI | acute kidney injury |
| AMPK | AMP-activated protein kinase |
| ApoE | Apolipoprotein E |
| AR | androgen receptor |
| ARB | angiotensin receptor blockers |
| BP | blood pressure |
| CHF | congestive heart failure |
| CKD | chronic kidney disease |
| CNS | central nervous system |
| CYP11B1 | cytochrome P450 family 11 subfamily B member 1 |
| CYP11B2 | cytochrome P450 family 11 subfamily B member 2 |
| DOCA | deoxycorticosterone acetate |
| EGFR | epidermal growth factor receptor |
| ENaC | epithelial sodium channels |
| EnC | endothelial cell |
| eGlx | endothelial cell glycocalyx |
| eNOS | endothelial nitric oxide synthase |
| ERK 1/2 | extracellular signal-regulated kinase 1/2 |
| ET-1 | endothelin-1 |
| FMD | flow-mediated dilatation |
| GPER (or GPR 30) | G-protein associated oestrogen receptor |
| HAC | human adrenocortical carcinoma |
| HEK | human embryonic kidney |
| HS | heparan sulphate |
| HUVEC | human umbilical vein endothelial cells |
| HYAL2 | hyaluronidase 2 |
| ICAM-1 | intercellular adhesion molecule-1 |
| MMP | matrix metalloproteinase |
| MR | mineralocorticoid receptor |
| NHE | Na+-H+ exchanger |
| NO | nitric oxide |
| ox-LDL | oxidized low-density lipoprotein |
| PR | progesterone receptor |
| RAAS | renin angiotensin aldosterone system |
| RCT | randomized controlled trial |
| SGK-1 | serum and glucocorticoid- induced kinase 1 |
| siRNA | small interfering RNA |
| St AR Protein | steroidogenic acute regulatory protein |
| VCAM-1 | vascular cell adhesion molecule-1 |